- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07945691
Imaging Follow-up After Stone Treatment
Imaging Follow-up of Patients With Urinary Stones: Ultrasound-Based Randomized Controlled Trial
Kidney stones are a common condition that can recur even after successful treatment. Regular imaging tests can help detect new stones, but frequent use of X-rays and CT scans can expose patients to unnecessary radiation. It is not yet clear how often patients should have imaging tests after treatment.
This study compares two schedules for monitoring patients who have undergone treatment for kidney stones and have no significant remaining stones. Participants are randomly assigned to one of two groups. One group has an ultrasound examination of the kidneys and urinary tract every 6 months, while the other group has the same examination every 12 months.
The study aims to determine whether more frequent ultrasound examinations can reduce unexpected episodes related to kidney stones, such as pain, bleeding in the urine, or urinary infections caused by blocked urine flow.
The researchers will also assess changes in kidney function, visits to the emergency department, the number of imaging tests performed, the development or growth of stones without symptoms, and the overall cost of imaging.
The study includes adults with a low or high risk of kidney stones recurrence and is conducted at Sismanoglio General Hospital in Athens, Greece.
The findings may help determine an appropriate schedule for monitoring patients after kidney stone treatment while reducing unnecessary tests, radiation exposure, and healthcare costs.
Descripción general del estudio
Estado
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Lazaros Tzelves
- Número de teléfono: 00306944104974
- Correo electrónico: lazarostzelves@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Panagiotis Neofytou
- Número de teléfono: 00306996288898
- Correo electrónico: neo.panagiotis@gmail.com
Ubicaciones de estudio
-
-
Attica
-
Athens, Attica, Grecia, 15126
- 2nd Department of Urology, Sismanoglio General Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Adults aged 18 years or older, including both males and females.
- Patients with urolithiasis of any stone composition.
- Patients with stones at any anatomical location.
- Patients undergoing any definitive stone treatment procedure, including extracorporeal shock wave lithotripsy (SWL), ureteroscopy (URS), retrograde intrarenal surgery (RIRS), or percutaneous nephrolithotomy (PCNL).
- Patients classified as either low-risk or high-risk for stone recurrence according to European Association of Urology (EAU) criteria.
- Patients with no significant residual stone fragments following treatment, defined as the absence of residual fragments larger than 2 mm at 4-6 weeks after the procedure, assessed by radiography and ultrasound or low-dose computed tomography.
Exclusion Criteria:
- Refusal to participate in the study.
- Patients with anatomical abnormalities or a history of previous open surgery for stone disease.
- Patients with a solitary kidney or chronic kidney disease.
- Patients with occupations considered to be associated with a high risk of stone disease, such as pilots.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: 6-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
|
Comparador activo: 12-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of Symptomatic Stone Episodes
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Occurrence of symptomatic stone episodes during a one-year follow-up period, defined as any of the following: a new episode of renal colic or pain, hematuria not attributable to another cause, or urinary tract infection associated with obstruction caused by a newly formed stone. In patients with no visible residual stone fragments after treatment, the detection of any stone during follow-up will be considered recurrence. In patients with residual fragments smaller than 2 mm, detection of any fragment measuring 3 mm or larger will be considered recurrence. |
from randomization until the end of follow-up period, 1 year after intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Estimated Glomerular Filtration Rate (eGFR)
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Change in estimated glomerular filtration rate (eGFR) during the follow-up period, as an indicator of changes in kidney function. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Emergency Department Visits
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Number of visits to the emergency department during the follow-up period. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Imaging Examinations Performed
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Total number of imaging examinations performed during the follow-up period for the evaluation of urolithiasis, including plain radiographs, computed tomography scans, and ultrasound examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Incidence of Asymptomatic Stone Growth
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Number of patients who develop asymptomatic stone growth during the follow-up period, as detected by imaging examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Total Cost of Imaging Examinations
Periodo de tiempo: from randomization until the end of follow-up period, 1 year after intervention
|
Total cost of imaging examinations performed during the follow-up period for the evaluation and monitoring of urolithiasis. |
from randomization until the end of follow-up period, 1 year after intervention
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades urogenitales masculinas
- Cálculos
- Condiciones Patológicas, Anatómicas
- Enfermedades urológicas
- Enfermedades urogenitales femeninas
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Condiciones Patológicas, Signos y Síntomas
- Cálculos urinarios
- Urolitiasis
Otros números de identificación del estudio
- 5949/21.01.2025
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .